R. Burioni et al., RECOMBINANT HUMAN FAB TO GLYCOPROTEIN-D NEUTRALIZES INFECTIVITY AND PREVENTS CELL-TO-CELL TRANSMISSION OF HERPES-SIMPLEX VIRUS-1 AND VIRUS-2 IN-VITRO, Proceedings of the National Academy of Sciences of the United Statesof America, 91(1), 1994, pp. 355-359
Herpes simplex viruses 1 and 2 (HSV-1 and -2) are associated with a nu
mber of conditions of varying severity, which are only partially respo
nsive to current therapies. Human antibodies to the viruses offer a po
tential alternative. We describe here the generation of panels of huma
n monoclonal Fab fragments to HSV-1 and -2 by panning a phage display
combinatorial antibody library against whole lysates from the two viru
ses. Each lysate selected a largely distinct set of Fabs, although all
of the Fabs were cross-reactive with both viruses. In a plaque-reduct
ion assay, one Fab neutralized HSV-1 at 0.25 mug/ml (50% reduction) an
d HSV-2 at 0.05 mug/ml. This Fab also inhibited plaque formation when
applied to virus-infected monolayers, completely abolishing HSV-2 plaq
ue development at 25 mug/ml 72 hr postinfection, indicating the abilit
y of the Fab to prevent cell-to-cell spread of virus. The Fab was show
n to recognize viral glycoprotein D and to neutralize virus primarily
by a postattachment mechanism. Recombinant Fabs may be useful for topi
cal administration, although whole antibody will probably be required
for systemic use.